---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-003617"
form_type: "8-K"
ticker: "CNTN"
cik: "0001861657"
company_name: "Canton Strategic Holdings, Inc."
filed_at: "2025-04-10T23:59:59+00:00"
generated_at: "2026-05-23T17:29:19.580296+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Tharimmune appoints Vincent LoPriore to Board of Directors

## Summary
- Board size increased to seven members on April 9, 2025.
- Vincent LoPriore appointed as new board member effective April 9, 2025.
- Tharimmune (NASDAQ: THAR) is a clinical-stage biopharmaceutical company.

## SEC filing metadata
- accession: 0001641172-25-003617
- form_type: 8-K
- ticker: CNTN
- cik: 0001861657
- company_name: Canton Strategic Holdings, Inc.
- filed_at: 2025-04-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1861657/000164117225003617/0001641172-25-003617-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1861657/000164117225003617/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-003617
- JSON: https://secwatch.observer/filing/0001641172-25-003617.json
- Plain text: https://secwatch.observer/filing/0001641172-25-003617.txt

## Key facts
- Executive change
  Vincent LoPriore was appointed as member of the Board at Canton Strategic Holdings, Inc..
  - Action: appointed
  - Role: member of the Board
  source text: appointed Vincent LoPriore as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1861657/000164117225003617/0001641172-25-003617-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.